Searched for
CONJUGATE VACCINE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Pfizer launches next-gen vaccine for pneumococcal diseasePfizer has introduced its 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India, offering protection against 20 serotypes re...
- Abbott launches 14-valent pneumococcal vaccine for children in IndiaAbbott India launched PneumoShield 14, a pneumonia vaccine for children aged six weeks and older. This vaccine offers broader protection th...
- India makes progress in child vaccination against diarrhoea, pneumonia amid pandemic: ReportNew Delhi, India made significant progress in 2020 in ensuring children receive immunisation that provide protection against diarrhoea and ...
- SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from WednesdayThe SII has to supply 2.4 crore doses of the vaccine to the Health Ministry by December 2021. It will be sent to 37 consignees all over Ind...
- Serum Institute launches India's first fully indigenously developed pneumococcal vaccinePNEUMOSIL has been developed through a collaboration spanning over a decade among Serum Institute of India Pvt Ltd, PATH and Bill and Melin...
- Vardhan launches India's first indigenously developed pneumococcal vaccine 'Pneumosil'During clinical trials, Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been l...
- Serum Institute develops first indigenous vaccine against pneumonia; to be launched next weekIndia's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase...
- India's 1st fully indigenously developed vaccine against pneumonia gets DCGI nodThe ministry said the vaccine will be used for active immunisatiuon against invasive disease and pneumonia caused by 'Streptococcus pneumon...
- Bharat Biotech's typhoid vaccine gets WHO pre-qualificationThis enables the procurement and supplies of this vaccine to UNICEF, Pan-American Health Organisation (PAHO) and GAVI-supported countries, ...
- WHO pre-qualifies Indian vaccine for typhoidHyderabad, Jan 3 (IANS) Bharat Biotech's Typhoid Conjugate Vaccine (TCV) against typhoid fever has received pre-qualification from the Worl...
- Pfizer's pneumonia vaccine now part of immunization programmeThe company's 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to prevent pneumonia has been selected for immunisation program in certain ...
- MSF and Pfizer battle over patent application for life-saving pneumonia vaccineMSF filed declarations at the Delhi patent office to point out that Pfizer's 13-valent pneumococcal conjugate vaccine (PCV13) was obvious a...
- DCVMN International to quicken access to affordable vaccinesDCVMN International announced its intention to support the programme regarding access to affordable high quality vaccines.
- Hyderabad pharma company Bharat Biotech unveils new typhoid vaccineBharat Biotech launched what it claimed was the world's first clinically proven typhoid conjugate vaccine, Typbar - TCV.
- Bharat Biotech launches conjugate typhoid vaccineBharat Biotech launched the world’s first clinically proven conjugate Typhoid vaccine ‘Typbar-TCV’, which offers long-term protection.
Load More
